Marker Therapeutics Statistics
Total Valuation
MRKR has a market cap or net worth of $20.42 million. The enterprise value is $9.09 million.
| Market Cap | 20.42M |
| Enterprise Value | 9.09M |
Important Dates
The last earnings date was Friday, August 14, 2026, after market close.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MRKR has 16.67 million shares outstanding. The number of shares has increased by 73.22% in one year.
| Current Share Class | 16.67M |
| Shares Outstanding | 16.67M |
| Shares Change (YoY) | +73.22% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 7.82% |
| Owned by Institutions (%) | 18.03% |
| Float | 13.74M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.64 |
| Forward PS | 3.83 |
| PB Ratio | 1.64 |
| P/TBV Ratio | 1.64 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.45 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.03
| Current Ratio | 6.03 |
| Quick Ratio | 5.35 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -76.87% and return on invested capital (ROIC) is -52.43%.
| Return on Equity (ROE) | -76.87% |
| Return on Assets (ROA) | -40.47% |
| Return on Invested Capital (ROIC) | -52.43% |
| Return on Capital Employed (ROCE) | -78.12% |
| Weighted Average Cost of Capital (WACC) | 12.68% |
| Revenue Per Employee | $709,334 |
| Profits Per Employee | -$1.74M |
| Employee Count | 5 |
| Asset Turnover | 0.24 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -15,156 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +28.42% in the last 52 weeks. The beta is 1.53, so MRKR's price volatility has been higher than the market average.
| Beta (5Y) | 1.53 |
| 52-Week Price Change | +28.42% |
| 50-Day Moving Average | 1.24 |
| 200-Day Moving Average | 1.44 |
| Relative Strength Index (RSI) | 48.75 |
| Average Volume (20 Days) | 61,579 |
Short Selling Information
The latest short interest is 139,192, so 0.83% of the outstanding shares have been sold short.
| Short Interest | 139,192 |
| Short Previous Month | 200,212 |
| Short % of Shares Out | 0.83% |
| Short % of Float | 1.01% |
| Short Ratio (days to cover) | 1.85 |
Income Statement
In the last 12 months, MRKR had revenue of $3.55 million and -$8.71 million in losses. Loss per share was -$0.47.
| Revenue | 3.55M |
| Gross Profit | -5.26M |
| Operating Income | -9.50M |
| Pretax Income | -8.72M |
| Net Income | -8.71M |
| EBITDA | n/a |
| EBIT | -9.50M |
| Loss Per Share | -$0.47 |
Balance Sheet
The company has $11.33 million in cash and no debt, with a net cash position of $11.33 million or $0.68 per share.
| Cash & Cash Equivalents | 11.33M |
| Total Debt | n/a |
| Net Cash | 11.33M |
| Net Cash Per Share | $0.68 |
| Equity (Book Value) | 12.17M |
| Book Value Per Share | 0.73 |
| Working Capital | 12.17M |
Cash Flow
| Operating Cash Flow | -9.76M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | -9.76M |
| FCF Per Share | -$0.59 |
Margins
Gross margin is -148.28%, with operating and profit margins of -267.95% and -245.51%.
| Gross Margin | -148.28% |
| Operating Margin | -267.95% |
| Pretax Margin | -245.94% |
| Profit Margin | -245.51% |
| EBITDA Margin | n/a |
| EBIT Margin | -267.95% |
| FCF Margin | n/a |
Dividends & Yields
MRKR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -73.22% |
| Shareholder Yield | -73.22% |
| Earnings Yield | -43.52% |
| FCF Yield | -48.76% |
Analyst Forecast
The average price target for MRKR is $7.87, which is 542.45% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $7.87 |
| Price Target Difference | 542.45% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 187.15% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 27, 2023. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jan 27, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
MRKR has an Altman Z-Score of -40.36 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -40.36 |
| Piotroski F-Score | 2 |